Palvella Therapeutics director Christopher P. Kiritsy disposes of 313 common shares for $49,141

• Director Christopher P. Kiritsy cut his Palvella Therapeutics stake to 250 shares on Sep. 2, 2026.
• Sold 313 common shares at USD 157 per share.
• Exercised stock options for 313 shares at USD 127.2 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palvella Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-105494), on September 04, 2026, and is solely responsible for the information contained therein.